Oral ondansetron for the control of delayed emesis after cisplatin: Report of a phase II study and a review of completed trials to manage delayed emesis Review uri icon

Overview

MeSH Major

  • Antiemetics
  • Cisplatin
  • Imidazoles
  • Nausea
  • Serotonin Antagonists
  • Vomiting

abstract

  • At the dose and schedule tested, oral ondansetron did not appear to control delayed emesis. Previous trials of programs to lessen this complication suggest that both metoclopramide and dexamethasone are effective in lessening delayed vomiting and that the combination of these drugs is more effective than placebo. Although in one trial ondansetron appeared to control delayed emesis in patients who received cisplatin at doses of 50-120 mg/m2, it was not superior to either placebo or metoclopramide in two randomized studies. Additional testing of the 5-HT3 antagonists, both alone and in combination, will be needed to establish their role in the management of this condition.

publication date

  • January 1992

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 1386282

Additional Document Info

start page

  • 1012

end page

  • 6

volume

  • 70

number

  • 4 SUPPL.